Soleno Therapeutics Inc
SLNODelisted May 18, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001484565
Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Soleno Therapeutics Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −1 vs. Q1 2022
- Shares held
- 48.8M
- −1.85M (−3.7%) vs. Q1 2022
- Total value
- $8.80M
- −$2.44M (−21.7%) vs. Q1 2022
- New holders
- 7
- 7 more added
- Sold out
- 8
- 11 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 227 | $2.09B |
| Q4 2025 | 248 | $3.01B |
| Q3 2025 | 240 | $4.41B |
| Q2 2025 | 234 | $4.75B |
| Q1 2025 | 217 | $3.90B |
| Q4 2024 | 166 | $2.29B |
| Q3 2024 | 142 | $2.38B |
| Q2 2024 | 114 | $1.79B |
| Q1 2024 | 98 | $1.52B |
| Q4 2023 | 76 | $1.26B |
| Q3 2023 | 54 | $598.8M |
| Q2 2023 | 23 | $21.8M |
| Q1 2023 | 21 | $7.06M |
| Q4 2022 | 26 | $6.00M |
| Q3 2022 | 22 | $5.23M |
| Q2 2022 | 40 | $8.80M |
| Q1 2022 | 41 | $11.2M |
| Q4 2021 | 39 | $11.8M |
| Q3 2021 | 39 | $27.1M |
| Q2 2021 | 47 | $33.6M |
| Q1 2021 | 63 | $41.2M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Soleno Therapeutics Inc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Abingworth LLP | 18,022,602 | $3.17M | 1.01% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 9,436,512 | $1.68M | 0.15% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 6,361,349 | $1.18M | 0.49% | −438,651−6.5% | Reduced |
| Birchview Capital, LP | 3,676,899 | $680.0K | 0.49% | 00.0% | Unchanged |
| Granite Point Capital Management, L.P. | 2,646,850 | $489.0K | 0.43% | 00.0% | Unchanged |
| Oracle Investment Management Inc | 2,132,000 | $394.0K | 0.12% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,035,806 | $377.0K | 0.00% | −16,045−0.8% | Reduced |
| Worth Venture Partners, LLC | 1,582,704 | $301.0K | 0.18% | −109,136−6.5% | Reduced |
| Renaissance Technologies LLC | 550,131 | $102.0K | 0.00% | +301,931+121.6% | Added |
| Geode Capital Management, LLC | 488,393 | $90.0K | 0.00% | +58,140+13.5% | Added |
| Citadel Advisors LLC | 295,312 | $55.0K | 0.00% | +150,689+104.2% | Added |
| Two Sigma Advisers, LP | 232,000 | $43.0K | 0.00% | −14,400−5.8% | Reduced |
| State Street Corp | 231,741 | $43.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 149,546 | $28.0K | 0.00% | −59,000−28.3% | Reduced |
| BNP Paribas Arbitrage, SA | 140,018 | $25.9K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 105,481 | $20.0K | 0.00% | 00.0% | Unchanged |
| Oppenheimer & Co Inc | 98,054 | $18.0K | 0.00% | −134,016−57.7% | Reduced |
| Commonwealth Equity Services, LLC | 100,000 | $18.0K | 0.00% | 00.0% | Unchanged |
| Warberg Asset Management LLC | 90,000 | $16.0K | 0.01% | +63,000+233.3% | Added |
| Virtu Financial LLC | 67,569 | $12.0K | 0.00% | +67,569 | New |
| Aspiriant, LLC | 57,295 | $11.0K | 0.00% | +40,000+231.3% | Added |
| UBS Group AG | 54,695 | $10.0K | 0.00% | +54,695 | New |
| Millennium Management LLC | 46,318 | $9.00K | 0.00% | +46,318 | New |
| Bank of New York Mellon Corp | 42,270 | $8.00K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 47,726 | $8.00K | 0.00% | +47,726 | New |
| Bollard Group LLC | 34,322 | $6.00K | 0.00% | 00.0% | Unchanged |
| Onyx Bridge Wealth Group LLC | 20,000 | $4.00K | 0.00% | +20,000 | New |
| Susquehanna International Group, LLP | 16,843 | $3.00K | 0.00% | +2,166+14.8% | Added |
| Avantax Planning Partners, Inc. | 10,700 | $2.00K | 0.00% | 00.0% | Unchanged |
| Levy Wealth Management Group, LLC | 10,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 12,724 | $2.00K | 0.00% | +12,724 | New |
| BlackRock Inc. | 5,156 | $1.00K | 0.00% | −125,161−96.0% | Reduced |
| Group One Trading, L.P. | 5,386 | $1.00K | 0.00% | −4,662−46.4% | Reduced |
| Tower Research Capital LLC (TRC) | 3,624 | $1.00K | 0.00% | −3,809−51.2% | Reduced |
| Advisor Group Holdings, Inc. | 1,120 | $0 | 0.00% | −1,920−63.2% | Reduced |
| JPMorgan Chase & Co | 94 | $0 | 0.00% | −1,507−94.1% | Reduced |
| Wells Fargo & Company | 651 | $0 | 0.00% | +302+86.5% | Added |
| Royal Bank of Canada | 137 | $0 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 1,100 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 526 | $0 | 0.00% | +526 | New |
| Empery Asset Management, LP | 0 | $0 | 0.00% | −1,401,400−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −252,154−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −128,454−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −13,387−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,998−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −156−100.0% | Sold out |
| Bray Capital Advisors | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |